ROCA Therapeutics. SIRET 89877818800018. Creation 28/04/2021 (Nice).
www.roca-therapeutics.org
Roca Therapeutics is a VC financed biotechnology start-up dedicated to the development of first-in-class small molecules against ocular diseases driven by hyper-vascularization and immuno-suppressive inflammation. Located in Nice (France), Roca Therapeutics has an internationally recognized team of Directors and Advisors with a strong track record of Translational Research and Drug Development in Oncology, Ophtalmology and Immunology. Roca Therapeutics has been rewarded by recognized prizes: i-Lab, BPIFrance BFTE, PIA3, Amgen Prize, …
Roca Therapeutics is founded since 2022 by a lead corporate VC and has been backed by several non-dilutive financings.
BiPER Therapeutics. SIRET 90207083800013. Creation 21/07/2021 (Strasbourg).
www.biper-tx.com
BiPER Therapeutics is a biotech company founded in 2021 to develop and commercialize novel therapeutics. It is developing a first-in-class pipeline of small molecules pushing cancer cells to burn out to treat cancers. BiPER ‘s name summarizes the original and unique approach of the Lead candidate targeting BiP and leading to cancer cell death through unresolved ER (Endoplasmic Reticulum) Stress induction. BiPER has an internationally recognized team of Directors and Advisors with a strong track record in Drug Discovery, Drug Development and Translational Research in Oncology associated with a solid experience in Biotech business and corporate development.